Journal of Health Sciences & Research

Register      Login

VOLUME 9 , ISSUE 2 ( December, 2018 ) > List of Articles

CASE REPORT

Treatment of Grade II Mandibular Furcation Defects by Concentrated Growth Factors and Hydroxyapatite Bone Substitute (Sybograf®): A Case Report

Krishna Kripal, Senthil Rajan, Kavita Chandrasekaran, Thaslim Fathima

Keywords : Concentrated growth factor, Furcation involvement, Hydroxyapatite crystals, Periodontal disease

Citation Information : Kripal K, Rajan S, Chandrasekaran K, Fathima T. Treatment of Grade II Mandibular Furcation Defects by Concentrated Growth Factors and Hydroxyapatite Bone Substitute (Sybograf®): A Case Report. J Health Sci Res 2018; 9 (2):61-65.

DOI: 10.5005/jp-journals-10042-1071

License: CC BY-NC 4.0

Published Online: 00-12-2018

Copyright Statement:  Copyright © 2018; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: This case report attempts an evaluation of the clinical and radiographic outcome of concentrated growth factors (CGF) along with nanohydroxyapatite bone substitute in considering grade II mandibular furcation defects. Background and objectives: Periodontal disease, if not interfered, will headway further with attachment loss, adequate enough to have a consequence on the bifurcation or trifurcation of multirooted teeth. There is a paucity of studies comparing the effects of CGF and nanohydroxyapatite crystals bone substitute in furcation defects. Case discussion: A male patient, 66 years old, had visited the outpatient department of periodontology, with a chief complaint of sensitivity in the lower left back tooth region for the past few months. The probing depth as measured by UNC-15 probe was 5 mm mesiobuccal, 10 mm midbuccal, 5 mm distobuccal and 5 mm midlingual. The furcation defect was filled using an appropriate combination of CGF and bone graft material (Sybograf). The flap was sutured with 3–0 silk suture to obtain primary closure. Conclusion: The results have shown significant improvement in the gingival index and probing pocket depth (horizontal and vertical). There was a significant amount of bone fill also that was evident radiographically. Clinical significance: The current case report boons a new approach for the treatment of grade II mandibular furcation defects through a collective approach of CGF and nanohydroxylapatite bone substitute.


PDF Share
  1. Asmita, Gupta V, Bains VK, Singh GP, Jhingran R. Clinical and cone beam computed tomography comparison of NovaBone Dental Putty and PerioGlas in the treatment of mandibular Class II furcations. Indian J Dent Res 2014;25:166-173.
  2. Singh VP, Nayak D, Uppoor AS, Shah D. Clinical and radiographic evaluation of Nano-crytalline hydroxyapatite bone graft (Sybograf®) in combination with bioresorbable collagen meme=brane (Periocol®) in periodontal intrabony defects. Dent Res J (Isfahan) 2012;9(1):60-67.
  3. Verma PK, Srivastava R, Gupta KK, Chaturvedi TP. Treatment strategy for guided tissue regeneration in various class II furcation defect: Case series. Dent Res J (Isfahan) 2013:10(5): 689-694.
  4. Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, et al. Comparative evaluation of autologous platelet-rich-brin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial. J Periodont Res 2013; 48:573-581.
  5. Qiao J, Jinyu Duan, Zhang Y, Chu Y, Sun C. The effect of concentrated growth factors in the treatment of periodontal intrabony defects. Future Science OA. 2016;2:4.
  6. Dogan SB, Dede FO, Balli U, Atalay EN, Durmuslar MC. Concentrated growth factor in the treatment of adjacent multiple gingival recessions: a split-mouth randomized clinical trial. J Clin Periodontol 2015;42:868-875.
  7. Pirpir C, Yilmaz O, Candirli C, Balaban E. Evaluation of effect iveness of concentrated growth factor on osseointegration. Int J implant Dent. 2017;3:7.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.